These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7993807)

  • 21. Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial.
    Jabbour E; Short NJ; Jain N; Huang X; Montalban-Bravo G; Banerjee P; Rezvani K; Jiang X; Kim KH; Kanagal-Shamanna R; Khoury JD; Patel K; Kadia TM; Daver N; Chien K; Alvarado Y; Garcia-Manero G; Issa GC; Haddad FG; Kwari M; Thankachan J; Delumpa R; Macaron W; Garris R; Konopleva M; Ravandi F; Kantarjian H
    Lancet Haematol; 2023 Jan; 10(1):e24-e34. PubMed ID: 36402146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interphase FISH for BCR-ABL1 rearrangement on neutrophils: A decisive tool to discriminate a lymphoid blast crisis of chronic myeloid leukemia from a de novo BCR-ABL1 positive acute lymphoblastic leukemia.
    Balducci E; Loosveld M; Rahal I; Boudjarane J; Alazard E; Missirian C; Lafage-Pochitaloff M; Michel G; Zattara H
    Hematol Oncol; 2018 Feb; 36(1):344-348. PubMed ID: 28444777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia in Lymphoid Blast Crisis.
    Kolenova A; Maloney KW; Hunger SP
    J Pediatr Hematol Oncol; 2016 Aug; 38(6):e193-5. PubMed ID: 27164534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of the rearrangement of the bcr/abl gene in extramedullary (lymph nodes) blast crisis diagnosed in chronic myeloid leukaemia.
    González FA; Villegas A; Ferro MT; Cabello P; Morales D; Perez J; Martinez R
    Br J Haematol; 1993 Jun; 84(2):351-2. PubMed ID: 8398844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FLANG (fludarabine + cytosine arabinoside + novantrone + G-CSF) induces partial remission in lymphoid blast transformation of Ph+chronic myelogenous leukaemia.
    Martinelli G; Testoni N; Zuffa E; Visani G; Zinzani PL; Zaccaria A; Farabegoli P; Arpinati M; Amabile M; Tura S
    Leuk Lymphoma; 1996 Jun; 22(1-2):173-6. PubMed ID: 8724545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast vs Ph+ acute lymphoblastic leukemia.
    Anastasi J; Feng J; Dickstein JI; Le Beau MM; Rubin CM; Larson RA; Rowley JD; Vardiman JW
    Leukemia; 1996 May; 10(5):795-802. PubMed ID: 8656674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biphenotypic blast crisis of chronic myelogenous leukemia: abnormalities of p53 and retinoblastoma genes.
    Ishikura H; Yufu Y; Yamashita S; Abe Y; Okamura T; Motomura S; Nishimura J; Nawata H
    Leuk Lymphoma; 1997 May; 25(5-6):573-8. PubMed ID: 9250829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonal instability preceding lymphoid blastic transformation of chronic myeloid leukemia.
    Spencer A; Vulliamy T; Kaeda J; Goldman JM; Melo JV
    Leukemia; 1997 Feb; 11(2):195-201. PubMed ID: 9009080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific point mutations that activate v-abl are not found in Philadelphia-negative chronic myeloid leukaemia, Philadelphia-negative acute lymphoblastic leukaemia or blast transformation of chronic myeloid leukaemia.
    Melo JV; Goldman JM
    Leukemia; 1992 Aug; 6(8):786-90. PubMed ID: 1353550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experience with using aclarubicin in the treatment of acute leukemia and blast crisis of chronic myeloid leukemia].
    Savchenko VG; Isaev VG; Abakumov EM; Khoroshko ND; Turkina AG; Sokolov AN; Viadro MM; Navashin SM
    Antibiot Khimioter; 1992 Jul; 37(7):47-9. PubMed ID: 1456812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonal succession and deletion of bcr/abl sequences in chronic myelogenous leukemia with recurrent lymphoid blast crisis.
    Laneuville P; Sullivan AK
    Leukemia; 1991 Sep; 5(9):752-6. PubMed ID: 1943228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disappearance of Ph1 chromosome with intensive chemotherapy and detection of minimal residual disease by polymerase chain reaction in a patient with blast crisis of chronic myelogenous leukemia.
    Honda H; Miyagawa K; Endo M; Takaku F; Yazaki Y; Hirai H
    Int J Hematol; 1993 Jun; 57(3):221-7. PubMed ID: 8364186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
    González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
    Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary research on the p53 gene rearrangements in the evolution of chronic myelogenous leukemia to blast crisis.
    Chen JC; Liu SM; Fei HB; Gong WL
    J Tongji Med Univ; 1994; 14(4):204-8. PubMed ID: 7760428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The spectrum of adult B-lymphoid leukemias with BCR-ABL: molecular diagnostic, cytogenetic, and clinical laboratory perspectives.
    Klco JM; Kreisel FH; Zehnbauer BA; Kulkarni S; Hassan A; Frater JL
    Am J Hematol; 2008 Dec; 83(12):901-7. PubMed ID: 18932238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A granulocytic population with rearranged immunogenotype in chronic myelocytic leukemia blast crisis and Philadelphia-chromosome-positive acute leukemia with cross-lineage nature.
    Kita K; Shimizu N; Miwa H; Ikeda T; Nishii K; Morita N; Uchida T; Shirakawa S; Tsutani H; Nasu K
    Leukemia; 1993 Feb; 7(2):251-7. PubMed ID: 8381195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone marrow cytogenetic complete remission achieved by interferon-alpha plus cytarabine ocfosfate therapy in a patient with chronic myelogenous leukemia during extramedullary blast crisis.
    Gotoh A; Miyazawa K; Uchida Y; Sashida G; Kawakubo K; Kuriyama Y; Ohyashiki K
    Int J Hematol; 2002 Feb; 75(2):191-4. PubMed ID: 11939268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pediatric Chronic Myelogenous Leukemia in T-lineage Blast Crisis: A Reminder in Relevance.
    Patel SA; Beck JC
    J Pediatr Hematol Oncol; 2022 Apr; 44(3):e707-e708. PubMed ID: 35319509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ph1-positive leukemia: cytogenetic outline and prognosis].
    Misawa S
    Nihon Rinsho; 1992 Jun; 50(6):1274-80. PubMed ID: 1518145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BCR rearrangements in Ph positive chronic myelocytic leukemia.
    Deng DS; Yang AD; Gong WL; Fei HB; Liu SM
    Chin Med J (Engl); 1991 Aug; 104(8):658-63. PubMed ID: 1680611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.